Adrenal masterclass 2022

The Radboudumc Adrenal Masterclass presents state of the art lectures and workshops on clinical and pathophysiological aspects of adrenal diseases. It serves an audience of adult and pediatric endocrinologists, clinical fellows, internists and clinical chemists who are involved in the management of patients with adrenal disease.

The duration of the masterclass is 4,5 days, from Monday to Friday. Many national and international experts contribute to an intensive program that encompasses all major adrenal disorders: hyper- and hypocortisolism, congenital adrenal hyperplasia, incidentaloma, adrenocortical cancer, pheochromocytoma/ paraganglioma and primary aldosteronism. Apart from overview lectures on theoretical and practical issues, there will be [...]

Continue reading

ESPE science symposium online

The ESPE science symposium aims to promote the development of an interactive network between clinicians and researchers, helping to reduce the gap between research and patient care. It will also provide the means to disseminate new scientific knowledge in the community of paediatric endocrinology. The symposium is organized every two years by a Local Organizing Committee (LOC) selected through an application process by the ESPE Science Committee.

Its focus will be ‘Congenital adrenal hyperplasia: from molecular medical research to clinical application’ and it will be supported by the Endo-ERN and the ESPE DSD Working Group.

The symposium will consist of [...]

Continue reading

EJP RD ERN Research Training Workshop Call

The European Joint Programme on Rare Diseases has launch the ERN Research Training Workshops funding opportunity. The goal of the workshops is to train researchers and clinicians affiliated to ERN- Full  Members or – Affiliated Partners in relevant topics on research in rare diseases. Training themes may include innovative research methodologies, diagnostic research methodologies, interdisciplinary treatment approaches, such as gene therapy and transplantation, etc. Moreover, the workshops will be aiming to provide a cross-ERN added value.

The workshops will be delivered as two-day events. The costs for the workshop organization will be covered up to a limit [...]

Continue reading

This entry was posted in General.

Endo-ERN symposium: Growth & Genetic Obesity Syndromes – Prader Willi Syndrome (PWS) Clinical management of transition of care

On Tuesday November 16th at 14:00 – 17:00 CET an Endo-ERN symposium with multiple speakers within the main thematic group of Growth & Genetic Obesity Syndromes is organised.

Program:

Prader Willi Syndrome (PWS) Clinical management of transition of care

2:00 – 2:30 Introduction – PWS as a model of hypothalamic obesity (Maithé Tauber- FR)

2:30 – 3:00 PWS and transition of care – focus on psychology (Tony Holland – UK)

3:00 – 3:45 PWS and transition of care – endocrine care of the young adults
Adrenal insufficiency and hypogonadism (Laura De Graaff – NL)
Growth hormone treatment [...]

Continue reading

Endo-ERN webinar: Overgrowth syndromes Beckwith Wiedemann syndrome and other rare conditions

On Tuesday September 7th at 17:00 – 18:00 CET an Endo-ERN webinar about “Overgrowth syndromes: Beckwith Wiedemann syndrome and other rare conditions” will be given by Frédéric Brioude from Hôpital Armand-Trousseau in France.

Overgrowth syndromes are a heterogeneous group of rare disorders characterized by generalized or segmental excessive growth, that can be associated with other features, including macrocephaly or cognitive impairment. These syndromes are caused by either genetic or epigenetic anomalies affecting factors involved in cell proliferation and/or the regulation of epigenetic markers. Overgrowth syndromes are frequently associated with an increased risk of cancer (embryonic tumours during infancy or carcinomas [...]

Continue reading

Vacancies: Phd positions – Better estimates of hormonal exposure to improve diagnosis and treatment in endocrine diseases (BEED-ED)

Are you interested in improving hormone measurements and implement your research findings into clinical practice?

In a joint research project, the departments of Endocrinology at Ghent University and KU Leuven are currently hiring two enthusiastic and highly motivated PhD researchers to participate in our new research project “Better estimates of hormonal exposure to improve diagnosis and treatment in endocrine diseases”. This project is funded by the TBM program of FWO Vlaanderen (Applied Biomedical Research with primary social finality) for a period of 4 years and will start October, 1st 2021.

Continue reading

This entry was posted in General.

Endo-ERN General Assembly 2022

The Endo-ERN General Assembly 2022 will be virtually held on Tuesday & Wednesday 15 & 16th of February 2022.

 

Tuesday 15th of February 2022

09:30 – 10:30 hrs Steering Committee & Advisory Board meeting
11.00 – 12.45 hrs GENERAL ASSEMBLY
13:30 – 16:00 hrs Meet and interact with your MTG co-workers

Wednesday 16th of February 2022

10:00 – 11:45 hrs GENERAL ASSEMBLY
12:30 – 15:00 hrs Meet and interact with your MTG co-workers

Continue reading

Prestigious EJPRD ERN Research Mobility Fellowship for drs. Eva Coopmans and drs. Oana Danila

The Research Mobility Fellowships of the European Joint Program on Rare Diseases (EJP RD) – The European Reference Networks (ERN) are awarded twice a year to a leading physician or researcher to gain new competencies and expertise in a European institution that specializes in research on rare diseases.

Eva Coopmans is a physician and researcher at the Center for Endocrine Tumors Leiden under the supervision of Prof. A.M. Pereira Arias and Prof. N.R. Biermasz. She received the EJP RD – ERN fellowship for ‘GH-secreting pituitary tumours: nip therapy resistance in the bud (pilot study)’. With this fellowship she can address [...]

Continue reading

This entry was posted in General.

Endo-ERN webinar: Update on the management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency

On Thursday September 9th at 15:00 – 16:00 CET an Endo-ERN webinar about “Update on the management of 46,XX Ovarian Dysgenesis and Primary Ovarian Insufficiency” will be given by Philippe Touraine from APHP-Pitié Salpêtrière Hospital in France.

Primary (premature) ovarian insufficiency (POI) is defined as a loss of ovarian activity before the age of 40, and is characterized by menstrual disturbances (amenorrhea or oligomenorrhea) with elevated gonadotropins (follicle-stimulating hormone [FSH] ≥ 25 IU/L) and low serum estradiol levels.The incidence of POI is around 1 per 100 women overall, and 1 per 1000 women under the age of 30 years. POI [...]

Continue reading